Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FUT8 | Q9BYC5 | 1/20 | 0.69 |
| ▸ | ENPP2 | Q13822 | 10/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
| ▸ | DNASE1L3 | Q13609 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | PHLPP2 | Q6ZVD8 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | CD40 | P25942 | 1/20 | 0.37 |
| ▸ | CD40LG | P29965 | 1/20 | 0.37 |
| ▸ | ATIC | P31939 | 1/20 | 0.37 |
| ▸ | CARM1 | Q86X55 | 1/20 | 0.36 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20390572 | 0.86 | FUT8 (0.81) | FUT8ENPP2MEN1KMT2ATHRB | |
| SCHEMBL17190771 | 0.84 | FUT8 (0.69) | FUT8ENPP2MEN1KMT2ATHRB | |
| SCHEMBL13474896 | 0.83 | FUT8 (1.00) | FUT8ENPP2MEN1KMT2ATHRB | |
| SCHEMBL31474592 | 0.83 | FUT8 (1.00) | FUT8ENPP2MEN1KMT2ATHRB | |
| SCHEMBL14135301 | 0.82 | FUT8 (0.92) | FUT8ENPP2MEN1KMT2ATHRB | |
| SCHEMBL12589955 | 0.82 | FUT8 (0.67) | FUT8ENPP2MEN1KMT2ATHRB | |
| SCHEMBL17481723 | 0.81 | FUT8 (0.63) | FUT8ENPP2MEN1KMT2ATHRB | |
| SCHEMBL30065554 | 0.80 | FUT8 (0.95) | FUT8ENPP2MEN1KMT2ATHRB | |
| SCHEMBL14529440 | 0.80 | FUT8 (0.95) | FUT8ENPP2MEN1KMT2ATHRB | |
| SCHEMBL25592390 | 0.80 | FUT8 (0.54) | FUT8ENPP2MEN1KMT2ATHRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170369721-A1 | INK COMPOSITION, INK SET, AND RECORDING METHOD | SEIKO EPSON CORPORATION (JP) | 2017-12-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170369721-A1 | INK COMPOSITION, INK SET, AND RECORDING METHOD | IK, SETDB1, SET | FUT8 2224/4885ENPP2 4283/4885MEN1 2221/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.